Latest FDA-Approved Drugs: Key Updates for Healthcare Professionals

Author: owner     Published: 1 month ago 0 Replies

Stay informed about the latest advancements in treatment options with these newly FDA-approved drugs:

  1. Emrelis (telisotuzumab vedotin-tllv) – Approved on May 14, 2025, for advanced or metastatic non-small cell lung cancer (NSCLC) with high c-Met protein overexpression.

  2. Avmapki Fakzynja Co-Pack (avutometinib + defactinib) – Approved on May 8, 2025, for KRAS-mutated low-grade serous ovarian cancer (LGSOC).

  3. Imaavy (nipocalimab-aahu) – Approved on April 29, 2025, for generalized myasthenia gravis.

  4. Penpulimab-kcqx – Approved on April 23, 2025, for recurrent or metastatic nasopharyngeal carcinoma (NPC) in combination or as monotherapy.

  5. Vanrafia (atrasentan) – Approved on April 2, 2025, for reducing proteinuria in primary IgA nephropathy.

  6. Qfitlia (fitusiran) – Approved on March 28, 2025, for preventing bleeding episodes in hemophilia A or B.

  7. Blujepa (gepotidacin) – Approved on March 25, 2025, for uncomplicated urinary tract infections.

  8. Romvimza (vimseltinib) – Approved on February 14, 2025, for tenosynovial giant cell tumors unamenable to surgery.

  9. Gomekli (mirdametinib) – Approved on February 11, 2025, for symptomatic neurofibromatosis type 1.

  10. Journavx (suzetrigine) – Approved on January 30, 2025, for moderate to severe acute pain.

  11. Grafapex (treosulfan) – Approved on January 21, 2025, for pre-transplant conditioning in AML and MDS.

  12. Datroway (datopotamab deruxtecan-dlnk) – Approved on January 17, 2025, for HR-positive, HER2-negative metastatic breast cancer.

Subscribe for updates and more ...

Login to Reply

Money Back Guarantee
We return Money in 24 Hours

Secure online payment
We possess SSL / Secure Certificate

12/7 customer support
Well-trained & Supportive team

PMDC Verified Doctors
Authentic & updated information

emedz.net

Book Online and In-clinic appointments with your doctor. Consult via Video chat and get a prescription. Ask any question in the "Forum" section and get a detailed answer. Discuss your health issues. Advertisers who wish to place ads on emedz.net and reach multiple users can contact here: ads@emedz.net

Connect with us

Copyright @ 2025 - All Rights Reserved Reproduction of material from any pages without permission is strictly prohibited.